Company Overview of Cary Pharmaceuticals Inc.
Cary Pharmaceuticals Inc., a pharmaceutical development company, engages in identifying and developing proprietary pharmaceutical products. It transits pharmaceutical products from basic research through Phase II clinical trials, and licenses to a strategic partner in exchange for upfront and milestone payments, as well as a royalty on net sales. The company is developing Tempol for the treatment of chronic hypertension; CPI-300; and QuitPak, an oral and non-nicotine product for smoking cessation. Cary Pharmaceuticals Inc. has strategic partnerships with Catalent Pharma Solutions and Intelgenx. The company was incorporated in 1994 and is based in Great Falls, Virginia.
9903 Windy Hollow Road
Great Falls, VA 22066
Founded in 1994
Key Executives for Cary Pharmaceuticals Inc.
Cary Pharmaceuticals Inc. Key Developments
Similar Private Companies By Industry
|Phage Pharmaceuticals, Inc.||United States|
|Angiomics, Inc.||United States|
|Pharmasset, Inc.||United States|
|Prevalere Life Sciences, Inc.||United States|
|ACGT, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Ohio | Boehringer IngelheimPosted: May 05
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
To contact Cary Pharmaceuticals Inc., please visit www.carypharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.